Connection

Elizabeth Garrett-Mayer to Sirolimus

This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Sirolimus.
Connection Strength

0.165
  1. Stromal cell-derived factor 1a mediates resistance to mTOR-directed therapy in pancreatic cancer. Neoplasia. 2012 Aug; 14(8):690-701.
    View in: PubMed
    Score: 0.094
  2. Pharmacodynamic-guided modified continuous reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumors. J Clin Oncol. 2008 Sep 01; 26(25):4172-9.
    View in: PubMed
    Score: 0.071
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.